# Vincenzo Silani

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/vincenzo-silani/

## Facts

| Field | Value |
| --- | --- |
| Citations | 28,287 |
| Field | Amyotrophic Lateral Sclerosis Research |
| h-index | 85 |
| i10-index | 340 |
| Last Known Institution | University of Milan |
| OpenAlex ID | https://openalex.org/A5028975603 |
| ORCID iD | https://orcid.org/0000-0002-7698-3854 |
| Works | 768 |

## Researcher papers

Showing 12 of 14.

- [EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force](https://scholariq.org/papers/efns-guidelines-on-the-clinical-management-of-amyotrophic-lateral-sclerosis-mals/)
- [Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways](https://scholariq.org/papers/exome-sequencing-in-amyotrophic-lateral-sclerosis-identifies-risk-genes-and/)
- [Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria](https://scholariq.org/papers/amyotrophic-lateral-sclerosis-frontotemporal-spectrum-disorder-als-ftsd-revised/)
- [Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis](https://scholariq.org/papers/mutations-in-the-profilin-1-gene-cause-familial-amyotrophic-lateral-sclerosis/)
- [Exome-wide Rare Variant Analysis Identifies TUBA4A Mutations Associated with Familial ALS](https://scholariq.org/papers/exome-wide-rare-variant-analysis-identifies-tuba4a-mutations-associated-with/)
- [Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy](https://scholariq.org/papers/second-asymptomatic-carotid-surgery-trial-acst-2-a-randomised-comparison-of/)
- [NEK1 variants confer susceptibility to amyotrophic lateral sclerosis](https://scholariq.org/papers/nek1-variants-confer-susceptibility-to-amyotrophic-lateral-sclerosis/)
- [Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?](https://scholariq.org/papers/clinical-trials-in-amyotrophic-lateral-sclerosis-why-so-many-negative-trials-and/)
- [Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i> -associated amyotrophic lateral sclerosis](https://scholariq.org/papers/poly-gp-proteins-are-a-useful-pharmacodynamic-marker-for-i-c9orf72-i-associated/)
- [Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis](https://scholariq.org/papers/mutations-in-the-vesicular-trafficking-protein-annexin-a11-are-associated-with/)
- [Primary lateral sclerosis: consensus diagnostic criteria](https://scholariq.org/papers/primary-lateral-sclerosis-consensus-diagnostic-criteria/)
- [The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder](https://scholariq.org/papers/the-c9orf72-expansion-mutation-is-a-common-cause-of-als-ftd-in-europe-and-has-a/)

## Researcher topics

- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Neurogenetic and Muscular Disorders Research](https://scholariq.org/topics/neurogenetic-and-muscular-disorders-research/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [Neurological diseases and metabolism](https://scholariq.org/topics/neurological-diseases-and-metabolism/)

## Researcher university

- [University of Milan](https://scholariq.org/institutions/university-of-milan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.